Immatics, a biotech company working on promising cell-based immunotherapies for solid cancers, has a promising TCR-engineered ...
Unlike chimeric antigen receptor (CAR) T-cell therapies, which can identify surface antigens, TCR-T cell therapies like ...
Macworld At a glance Expert's Rating Pros ・Quick, stable performance combined with a handy user interface made navigation and ...